463 A multicenter phase II study of capecitabine plus paclitaxel in metastatic breast cancer: Survival update

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90495-2 ◽

2003 ◽

Vol 1 (5) ◽

pp. S141 ◽

Author(s):

W. Gradishar ◽

L. Meza ◽

T. Hill ◽

D. Samid ◽

Y.-M. Chen ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Cancer Survival ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Survival ◽

Multicenter Phase

Download Full-text

5002 MoniCa: A multicenter phase II study to determine the efficacy of capecitabine as first line monochemotherapy in patients with HER2 negative, medium-risk, metastatic breast cancer (GBG39)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70894-8 ◽

2009 ◽

Vol 7 (2) ◽

pp. 260 ◽

Author(s):

M. Kaufmann ◽

M.W. Sütterlin ◽

I. Schrader ◽

B. Gerber ◽

W. Bauer ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Multicenter Phase ◽

Medium Risk ◽

Negative Medium

Download Full-text

Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)

Annals of Oncology ◽

10.1093/annonc/mdp536 ◽

2010 ◽

Vol 21 (7) ◽

pp. 1442-1447 ◽

Author(s):

E.M. Ciruelos ◽

J. Cortés ◽

H. Cortés-Funes ◽

J.I. Mayordomo ◽

B. Bermejo ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Multicenter Phase

Download Full-text

Combination docetaxel and trastuzumab treatment for patients with her-2-overexpressing metastatic breast cancer: A multicenter, phase-II study

Breast Cancer ◽

10.2325/jbcs.13.166 ◽

2006 ◽

Vol 13 (2) ◽

pp. 166-171 ◽

Author(s):

Nobuaki Sato ◽

Muneaki Sano ◽

Toshio Tabei ◽

Taro Asaga ◽

Jiro Ando ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Trastuzumab Treatment ◽

Multicenter Phase ◽

Download Full-text

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-005-9030-x ◽

2005 ◽

Vol 95 (1) ◽

pp. 45-53 ◽

Author(s):

M. Venturini ◽

C. Bighin ◽

S. Monfardini ◽

F. Cappuzzo ◽

N. Olmeo ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Preliminary results of multicenter phase II study off docetaxel and 5′-deoxy-5-fluorouridine, an intermediate form of capecitabine, for pretreated metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80222-2 ◽

2002 ◽

Vol 38 (11) ◽

pp. S73-S74

Author(s):

S Mitsuyama

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Intermediate Form ◽

Preliminary Results ◽

Multicenter Phase

Download Full-text

The utility of bi-weekly eribulin therapy for metastatic breast cancer: A Japanese multicenter phase II study (JUST-STUDY).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.1026 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 1026-1026 ◽

Author(s):

Tetsuhiro Yoshinami ◽

Norikazu Masuda ◽

Takahiro Nakayama ◽

Fumikata Hara ◽

Yasuaki Sagara ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Multicenter Phase

Download Full-text

Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy

Annals of Oncology ◽

10.1093/annonc/mdg346 ◽

2003 ◽

Vol 14 (8) ◽

pp. 1227-1233 ◽

Author(s):

P. Reichardt ◽

G. von Minckwitz ◽

P.C. Thuss-Patience ◽

W. Jonat ◽

H. Kölbl ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Oral Capecitabine ◽

Multicenter Phase

Download Full-text

Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer

10.1186/1471-2407-14-820 ◽

2014 ◽

Vol 14 (1) ◽

Author(s):

Xichun Hu ◽

Jun Cao ◽

Wenwei Hu ◽

Changping Wu ◽

Yueyin Pan ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Study ◽

Metastatic Breast ◽

Multicenter Phase

Download Full-text

Multicenter phase II study of combination chemotherapy with capecitabine and intravenous vinorelbine in patients with pretreated metastatic breast cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/j.1743-7563.2006.00083.x ◽

2007 ◽

Vol 3 (1) ◽

pp. 37-43 ◽

Author(s):

Alison J DAVIS ◽

Sue BREW ◽

Val J GEBSKI ◽

Craig R LEWIS ◽

Eugene MOYLAN ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Phase Ii Study ◽

Metastatic Breast ◽

Multicenter Phase

Download Full-text

Abstract P4-12-08: Final efficacy results from a single-arm multicenter phase II study evaluating first-line trastuzumab, bevacizumab, and capecitabine (HAX) therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC)

10.1158/0008-5472.sabcs13-p4-12-08 ◽

2013 ◽

Author(s):

M Martín ◽

A Makhson ◽

J Gligorov ◽

M Lichinitser ◽

A Lluch ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Her2 Positive ◽

Multicenter Phase ◽

Locally Recurrent

Download Full-text